Personal Information
Organización/Lugar de trabajo
Porto Area, Portugal Portugal
Ocupación
Medical Doctor na Unidade Local de Saúde do Nordeste - Unidade Hospitalar de Mirandela
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://hugomls.no.sapo.pt
Acerca de
Hugo Sousa is currently a Biomedical Scientist at the Portuguese Oncology institute of Porto (Porto, Portugal) working in the Virology Service with special focus on herpesviruses (EBV, CMV) and human papillomavirus (HPV). He is also a senior researcher of the Molecular Oncology and Viral Pathology Group (CI-IPOPorto).
His academic career started with a BScH in Microbiology; a Master Degree in Oncology developed at the Imperial College Faculty of Medicine (London UK) working with Epstein-Barr Virus; a PhD in Biomedical Sciences developed at Portuguese Oncology institute of Porto (Porto, Portugal) working with genetic susceptibility markers of viral associated neoplasias; and just recently...
Presentaciones
(12)Recomendaciones
(2)Central nervous system pathology
Kristine Faith Tablizo
•
Hace 8 años
Testes parametricos e nao parametricos
Rosario Cação
•
Hace 14 años
Personal Information
Organización/Lugar de trabajo
Porto Area, Portugal Portugal
Ocupación
Medical Doctor na Unidade Local de Saúde do Nordeste - Unidade Hospitalar de Mirandela
Sector
Medical / Health Care / Pharmaceuticals
Sitio web
http://hugomls.no.sapo.pt
Acerca de
Hugo Sousa is currently a Biomedical Scientist at the Portuguese Oncology institute of Porto (Porto, Portugal) working in the Virology Service with special focus on herpesviruses (EBV, CMV) and human papillomavirus (HPV). He is also a senior researcher of the Molecular Oncology and Viral Pathology Group (CI-IPOPorto).
His academic career started with a BScH in Microbiology; a Master Degree in Oncology developed at the Imperial College Faculty of Medicine (London UK) working with Epstein-Barr Virus; a PhD in Biomedical Sciences developed at Portuguese Oncology institute of Porto (Porto, Portugal) working with genetic susceptibility markers of viral associated neoplasias; and just recently...